筛选条件 共查询到126条结果
排序方式
Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study

期刊: DIGESTIVE AND LIVER DISEASE, 2020; 52 (8)

Background: Incidence of inflammatory bowel disease (IBD) is increasing in newly industrialised countries (NICs); however, data on suboptimal response......

Esophageal cancer cells convert the death signal from TRAIL into a stimulus for survival during acid/bile exposure

期刊: DIGESTIVE AND LIVER DISEASE, 2020; 52 (10)

Background: TRAIL is best known for killing cancer cells selectively, however, some cancers resist TRAIL treatment for various reasons. Esophageal ade......

Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases

期刊: DIGESTIVE AND LIVER DISEASE, 2020; 52 (10)

Objective: To explore the clinical characteristics of Coronavirus Disease (COVID-19) patients with gastrointestinal symptoms. Methods: The clinical da......

Expression of DCP1a in gastric cancer and its biological function and mechanism in chemotherapy resistance in gastric cancer cells

期刊: DIGESTIVE AND LIVER DISEASE, 2020; 52 (11)

Aims: To detect the role of DCP1a in gastric cancer. To estimate the effect of DCP1a in gastric cancer cells on proliferation, invasion, migration and......

Mechanism of aberrant long non-coding RNA expression in an adriamycin-resistant liver cancer cell strain

期刊: DIGESTIVE AND LIVER DISEASE, 2020; 52 (5)

Background and aims: Aberrant long non-coding RNA (lncRNA) expression in cancer can be used as a potential diagnostic biomarker and therapeutic target......

IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-kappa B signaling pathway

期刊: DIGESTIVE AND LIVER DISEASE, 2020; 52 (5)

Background: Hepatocellular carcinoma (HCC) is one of the most lethal cancers owing to the high metastasis rate. The molecular mechanism underlying HCC......

共126条页码: 1/9页15条/页
打开APP